Cargando…

A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China

OXA-232 carbapenemase is becoming a threat in China due to its high prevalence, mortality, and limited treatment options. However, little information is available on the impact of OXA-232-producing Klebsiella pneumoniae in China. This study aims to characterize the clonal relationships, the genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Siquan, Han, Renru, Yin, Dandan, Jiang, Bo, Ding, Li, Guo, Yan, Wu, Shi, Wang, Chuning, Zhang, Hong, Hu, Fupin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269757/
https://www.ncbi.nlm.nih.gov/pubmed/37102869
http://dx.doi.org/10.1128/spectrum.03863-22
_version_ 1785059242512744448
author Shen, Siquan
Han, Renru
Yin, Dandan
Jiang, Bo
Ding, Li
Guo, Yan
Wu, Shi
Wang, Chuning
Zhang, Hong
Hu, Fupin
author_facet Shen, Siquan
Han, Renru
Yin, Dandan
Jiang, Bo
Ding, Li
Guo, Yan
Wu, Shi
Wang, Chuning
Zhang, Hong
Hu, Fupin
author_sort Shen, Siquan
collection PubMed
description OXA-232 carbapenemase is becoming a threat in China due to its high prevalence, mortality, and limited treatment options. However, little information is available on the impact of OXA-232-producing Klebsiella pneumoniae in China. This study aims to characterize the clonal relationships, the genetic mechanisms of resistance, and the virulence of OXA-232-producing K. pneumoniae isolates in China. We collected 81 OXA-232-producing K. pneumoniae clinical isolates from 2017 to 2021. Antimicrobial susceptibility testing was performed using the broth microdilution method. Capsular types, multilocus sequence types, virulence genes, antimicrobial resistance (AMR) determinants, plasmid replicon types, and single-nucleotide polymorphism (SNP) phylogeny were inferred from whole-genome sequences. OXA-232-producing K. pneumoniae strains were resistant to most antimicrobial agents. These isolates showed partial differences in susceptibility to carbapenems: all strains were resistant to ertapenem, while the resistance rates to imipenem and meropenem were 67.9% and 97.5%, respectively. Sequencing and capsular diversity analysis of the 81 K. pneumoniae isolates revealed 3 sequence types (ST15, ST231, and one novel ST [ST-V]), 2 K-locus types (KL112 and KL51), and 2 O-locus types (O2V1 and O2V2). The predominant plasmid replicon types associated with the OXA-232 and rmtF genes were ColKP3 (100%) and IncFIB-like (100%). Our study summarized the genetic characteristics of OXA-232-producing K. pneumoniae circulating in China. The results demonstrate the practical applicability of genomic surveillance and its utility in providing methods to prevent transmission. It alerts us to the urgent need for longitudinal surveillance of these transmissible lineages. IMPORTANCE In recent years, the detection rate of carbapenem-resistant K. pneumoniae has increased and represents a major threat to clinical anti-infective therapy. Compared with KPC-type carbapenemases and NDM-type metallo-β-lactamases, OXA-48 family carbapenemases are another important resistance mechanism mediating bacterial resistance to carbapenems. In this study, we investigated the molecular characteristics of OXA-232 carbapenemase-producing K. pneumoniae isolated from several hospitals to clarify the epidemiological dissemination characteristics of such drug-resistant strains in China.
format Online
Article
Text
id pubmed-10269757
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-102697572023-06-16 A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China Shen, Siquan Han, Renru Yin, Dandan Jiang, Bo Ding, Li Guo, Yan Wu, Shi Wang, Chuning Zhang, Hong Hu, Fupin Microbiol Spectr Research Article OXA-232 carbapenemase is becoming a threat in China due to its high prevalence, mortality, and limited treatment options. However, little information is available on the impact of OXA-232-producing Klebsiella pneumoniae in China. This study aims to characterize the clonal relationships, the genetic mechanisms of resistance, and the virulence of OXA-232-producing K. pneumoniae isolates in China. We collected 81 OXA-232-producing K. pneumoniae clinical isolates from 2017 to 2021. Antimicrobial susceptibility testing was performed using the broth microdilution method. Capsular types, multilocus sequence types, virulence genes, antimicrobial resistance (AMR) determinants, plasmid replicon types, and single-nucleotide polymorphism (SNP) phylogeny were inferred from whole-genome sequences. OXA-232-producing K. pneumoniae strains were resistant to most antimicrobial agents. These isolates showed partial differences in susceptibility to carbapenems: all strains were resistant to ertapenem, while the resistance rates to imipenem and meropenem were 67.9% and 97.5%, respectively. Sequencing and capsular diversity analysis of the 81 K. pneumoniae isolates revealed 3 sequence types (ST15, ST231, and one novel ST [ST-V]), 2 K-locus types (KL112 and KL51), and 2 O-locus types (O2V1 and O2V2). The predominant plasmid replicon types associated with the OXA-232 and rmtF genes were ColKP3 (100%) and IncFIB-like (100%). Our study summarized the genetic characteristics of OXA-232-producing K. pneumoniae circulating in China. The results demonstrate the practical applicability of genomic surveillance and its utility in providing methods to prevent transmission. It alerts us to the urgent need for longitudinal surveillance of these transmissible lineages. IMPORTANCE In recent years, the detection rate of carbapenem-resistant K. pneumoniae has increased and represents a major threat to clinical anti-infective therapy. Compared with KPC-type carbapenemases and NDM-type metallo-β-lactamases, OXA-48 family carbapenemases are another important resistance mechanism mediating bacterial resistance to carbapenems. In this study, we investigated the molecular characteristics of OXA-232 carbapenemase-producing K. pneumoniae isolated from several hospitals to clarify the epidemiological dissemination characteristics of such drug-resistant strains in China. American Society for Microbiology 2023-04-27 /pmc/articles/PMC10269757/ /pubmed/37102869 http://dx.doi.org/10.1128/spectrum.03863-22 Text en Copyright © 2023 Shen et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Shen, Siquan
Han, Renru
Yin, Dandan
Jiang, Bo
Ding, Li
Guo, Yan
Wu, Shi
Wang, Chuning
Zhang, Hong
Hu, Fupin
A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China
title A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China
title_full A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China
title_fullStr A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China
title_full_unstemmed A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China
title_short A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla(OXA-232) and rmtF in China
title_sort nationwide genomic study of clinical klebsiella pneumoniae carrying bla(oxa-232) and rmtf in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269757/
https://www.ncbi.nlm.nih.gov/pubmed/37102869
http://dx.doi.org/10.1128/spectrum.03863-22
work_keys_str_mv AT shensiquan anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT hanrenru anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT yindandan anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT jiangbo anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT dingli anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT guoyan anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT wushi anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT wangchuning anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT zhanghong anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT hufupin anationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT shensiquan nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT hanrenru nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT yindandan nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT jiangbo nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT dingli nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT guoyan nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT wushi nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT wangchuning nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT zhanghong nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina
AT hufupin nationwidegenomicstudyofclinicalklebsiellapneumoniaecarryingblaoxa232andrmtfinchina